Label: DIBUCAINE TOPICAL ANESTHETIC 1% HEMORRHOIDAL- dibucaine ointment
- NDC Code(s): 0536-1211-95
- Packager: Rugby Laboratories Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated October 24, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Active ingredient
- Use
-
Warnings
For external use only.
Allergy Alert
- Certain persons can develop allergic reactions to ingredients in this product. If the symptoms being treated does not subside or if redness, irritaion, swelling, bleeding or other symptoms develop or increase, discontinue use and ask a doctor.
-
Directions
- adults and children 12 years and over: If possible, clean the affected area with mild soap and warm water and rinse thoroughly. Dry by patting or with toilet tissue or a soft cloth before applying.
- apply externally to the affected area up to 3 to 4 times daily.
- children under 12 years of age: ask a doctor
- Other information
- undefined
- Questions or comments?
- Package Labeling:
-
INGREDIENTS AND APPEARANCE
DIBUCAINE TOPICAL ANESTHETIC 1% HEMORRHOIDAL
dibucaine ointmentProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:0536-1211 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DIBUCAINE (UNII: L6JW2TJG99) (DIBUCAINE - UNII:L6JW2TJG99) DIBUCAINE 10 mg in 1 g Inactive Ingredients Ingredient Name Strength LANOLIN (UNII: 7EV65EAW6H) LIGHT MINERAL OIL (UNII: N6K5787QVP) WATER (UNII: 059QF0KO0R) PETROLATUM (UNII: 4T6H12BN9U) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:0536-1211-95 1 in 1 BOX 08/19/2019 1 28 g in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M015 08/19/2019 Labeler - Rugby Laboratories Inc. (079246066)